(August 18, 2015, 1:33 PM EDT) -- WASHINGTON, D.C. — Centralization of at least 43 federal Cymbalta withdrawal complaints will again be considered at the Oct. 1 meeting of the Judicial Panel on Multidistrict Litigation (JPMDL), the panel announced Aug. 14 (In Re: Cymbalta [Duloxetine] Products Liability Litigation, MDL Docket No. 2662, JPMDL).

On July 23, 52 plaintiffs filed a new motion for a Cymbalta withdrawal multidistrict litigation with the JPMDL. They say that since the panel rejected an MDL petition in December 2014, all plaintiffs are on the same discovery schedule and...